Skip survey header

Value in Prescribing bDMARDs program - Rheumatology survey

Information sheet

A consortium of nine organisations (the Targeted Therapies Alliance) led by NPS MedicineWise, has been funded by the Australian Government Department of Health for a three-year program which aims to optimise the use of biological disease-modifying antirheumatic drugs (bDMARDs) and achieve better health and economic outcomes.    
The Alliance includes the following organisations:   
  • Arthritis Australia  
  • Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network  
  • Australian Rheumatology Association  
  • Cochrane Musculoskeletal  
  • Council of Australian Therapeutic Advisory Groups  
  • NPS MedicineWise  
  • Pharmaceutical Society of Australia  
  • Quality Use of Medicines and Pharmacy Research Centre (University of South Australia)   
  • Society of Hospital Pharmacists of Australia.  
The Alliance and stakeholders are co-designing a comprehensive range of evidence and data driven educational activities to support the program.  We are inviting you to participate in a survey as part of this program. This survey asks you to reflect on your attitudes, knowledge and practice with regards to the management of Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA). Your responses will assist us in the evaluation of this program to inform planning of future activities and resources in this area.

We appreciate your time and would be grateful if you could assist us by completing the following questionnaire. The questionnaire will take approximately 10 minutes to complete. 

Your responses are confidential and will be aggregated for reporting purposes. Participation in this survey is voluntary and will not have any impact on your relationship with the Australian Rheumatology Association, NPS MedicineWise or any of the above organisations. By completing the following questionnaire, you are providing implied consent for your responses to be used for evaluation purposes. 

If you have any questions please contact Dr Isla Hains,

This project has ethics approval from the Central Adelaide Local Health Network (CALHN) Human Research Ethics Committee (Reference number: 13647). If you have any concerns about how the study is being conducted or the consent process, please contact the committee on 08 7117 2224. 

Please click Next to continue on with the questionnaire.